BBIO·BridgeBio Pharma Inc.
BBIO|Analyst Targets
BBIO|Insider Trading
BBIO|Fundamentals
BBIO|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $-0.63 | - | - |
| Q2'25 | $-0.60 | $-0.95 | -57.1% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $276M | - | - |
| Q2'25 | - | - | - |
BBIO|Monthly Returns
Market Data
BBIO Stock Snapshot
- Market cap
- 12.38B
- Day range
- $62.86 – $65.36
- News sentiment
- 70/100 · Bullish
- Analyst target
- $109.05 (+67.9%)
- Consensus
- Buy · 31 analysts
Momentum is working in BBIO's favour - it ranks in the upper part of DailyIQ's momentum universe. The stock is liquid enough that positioning changes get absorbed without distorting the trend.
Behaviour On Record
What BBIO's own history says about today's numbers
- Realized volatility (21d)
- 43.8% 25th pct
- Below its peak
- -29.9%
- vs 200-day average
- -13.7%
- Up days (1y)
- 51%
BridgeBio Pharma Inc. is currently running 43.8% annualised volatility over the last 21 sessions. Measured against BBIO's own 7 years of daily returns rather than a market-wide average, that is the 25th percentile — unusually subdued by its own history, against a typical reading of 57.6%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
BBIO is trading -29.9% below its running peak. Across 6 full years on file, its median worst-drawdown-in-a-year was -50.4%, and the deepest was -80.1% in 2021. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits -13.7% from its 200-day moving average. Against every other day in its history, that gap ranks at the 21st percentile — a narrower gap than it typically runs. Over the past year BBIO closed higher on 51% of sessions, and it is currently 1 session into a falling streak.
On October specifically: over 7 years of records, BBIO finished the month higher 5 of 7 times, with a median return of +2.5% and an average of +3.7%. Its strongest month historically has been June at +12.7% on average, its weakest September at -5.5%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: BBIO has opened more than 2% away from the prior close in 332 of 1,829 sessions (18.2% of the time), with the largest gaps running +20.9% and -12.2%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 1,831 daily closes between 2019-06-27 and 2026-10-13, split-adjusted, recomputed daily. Percentiles are against BBIO's own 7-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of BBIO's sector?
BridgeBio Pharma Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Biotechnology industry group, BBIO ranks 9th of 15 tracked industries, improving.
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 82
- Industry rank
- #9 of 15
Analyst Rating Changes
Are analysts turning bullish or bearish on BBIO?
Barclays most recently reiterated its rating on BridgeBio Pharma Inc. to Overweight on Oct 7, 2026 with a price target of $156 (from $157). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- Barclays — Overweight
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
ETF holders
ETFs holding BBIO
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▲ Buy | 16,862,691 | 8.58% | $1.29B | 2026-01-29 |
| Janus Henderson Group plc | ▲ Buy | 13,179,013 | 6.71% | $978.61M | 2026-05-18 |
| BlackRock, Inc. | ▼ Sell | 10,287,156 | 5.24% | $766.19M | 2026-08-07 |
| Viking Global Investors LP | ▼ Sell | 9,949,219 | 5.07% | $741.02M | 2026-08-14 |
| Wellington Management Group LLP | ▲ Buy | 5,308,924 | 2.70% | $395.41M | 2026-08-14 |
| Two Sigma Investments, LP | ▲ Buy | 4,722,185 | 2.40% | $351.71M | 2026-08-14 |
| Citadel Advisors LLC | ▲ Buy | 3,760,028 | 1.91% | $280.05M | 2026-09-02 |
| Invesco Ltd. | ▼ Sell | 3,700,934 | 1.88% | $275.65M | 2026-08-14 |
| D. E. Shaw & Co., Inc. | ▲ Buy | 3,633,007 | 1.85% | $270.59M | 2026-08-14 |
| Geode Capital Management, LLC | ▼ Sell | 3,418,419 | 1.74% | $254.67M | 2026-08-12 |
| JPMorgan Chase & Co | ▲ Buy | 2,397,995 | 1.22% | $173.23M | 2026-08-12 |
| Adage Capital Partners GP, L.L.C. | ▲ Buy | 2,252,000 | 1.15% | $167.73M | 2026-08-14 |
| FMR LLC (Fidelity) | ▼ Sell | 2,061,307 | 1.05% | $153.53M | 2026-08-13 |
| Goldman Sachs Group Inc | ▼ Sell | 1,814,657 | 0.92% | $135.16M | 2026-08-14 |
| Norges Bank | ▲ Buy | 1,693,773 | 0.86% | $126.15M | 2026-08-12 |
| Morgan Stanley | ▼ Sell | 1,693,652 | 0.86% | $126.14M | 2026-08-13 |
| Point72 Asset Management, L.P. | ▲ Buy | 1,525,782 | 0.78% | $113.64M | 2026-08-14 |
| AllianceBernstein L.P. | ▼ Sell | 1,453,504 | 0.74% | $107.94M | 2026-08-14 |
| Bank of America Corp | ▼ Sell | 1,235,380 | 0.63% | $92.01M | 2026-08-14 |
| Balyasny Asset Management L.P. | ▲ Buy | 1,230,052 | 0.63% | $91.61M | 2026-08-14 |
| Squarepoint Ops LLC | ▲ Buy | 1,191,732 | 0.61% | $88.76M | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 959,513 | 0.49% | $71.46M | 2026-08-13 |
| Citigroup Inc | ▲ Buy | 864,101 | 0.44% | $64.36M | 2026-08-03 |
| Renaissance Technologies LLC | ▲ Buy | 856,846 | 0.44% | $63.82M | 2026-08-13 |
| Capital Research Global Investors | ▼ Sell | 700,107 | 0.36% | $52.14M | 2026-08-12 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Gilbert Cisneros | House | CA31 | ▼ Sell | $1K - $15K | 2026-09-29 | 2026-10-12 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-04-29 | 2026-05-08 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-03-19 | 2026-04-07 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-03-18 | 2026-04-07 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-03-03 | 2026-04-07 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2025-09-22 | 2025-10-10 |